Picard Medical reported revenue of $2.95M and net income of -$5.66M for the quarter ended Jun 2026, up 38.6% year over year. This income statement covers 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.16M | 0.19M | 0.16M | 0.16M | 0.19M | 1.09M | 0.72M | 1.51M | 2.06M |
| Revenue & cost | |||||||||
| Revenue | 0.69M | 0.88M | 0.84M | 0.62M | 2.13M | 1.19M | 1.01M | 1.15M | 2.95M |
| Gross Profit | -0.38M | -0.67M | 0.14M | -0.36M | -0.13M | -0.13M | 0.41M | 0.28M | 0.62M |
| Operating items | |||||||||
| Research & DevelopmentR&D | 0.94M | 0.96M | 0.79M | 0.81M | 0.74M | 0.95M | 0.55M | 1.90M | 1.37M |
| Selling, General & AdministrativeSG&A | 2.50M | 2.81M | 2.92M | 2.08M | 2.65M | 2.41M | 2.87M | 2.89M | 3.87M |
| Operating ExpensesOpex | 3.44M | 3.77M | 3.71M | 2.89M | 3.39M | 3.36M | 3.41M | 4.79M | 5.25M |
| Operating IncomeOp. Inc | -3.82M | -4.44M | -3.57M | -3.25M | -3.52M | -3.49M | -3.00M | -4.51M | -4.63M |
| EBIT | -3.82M | -4.44M | -3.57M | -3.25M | -3.52M | -3.49M | -3.00M | -4.51M | -4.63M |
| Non-operating items | |||||||||
| Non Operating Interest Expenses | 0.17M | 2.43M | |||||||
| Interest & Investment IncomeInt & Inv Inc | -1.38M | -1.43M | -0.56M | -2.43M | -2.40M | -0.01M | -0.01M | -0.09M | |
| Other Non Operating IncomeOther Non Op Inc. | -0.38M | -3.85M | -1.73M | -0.78M | -4.54M | -6.10M | -3.19M | ||
| Non Operating IncomeNon Op. Inc. | -1.76M | -5.28M | -2.28M | -3.20M | -6.94M | -1.28M | -3.10M | -1.02M | |
| Net income details | |||||||||
| EBT | -4.06M | -6.21M | -8.85M | -5.53M | -6.72M | -10.43M | -4.32M | -7.62M | -5.65M |
| Tax ProvisionsTaxes | -4.42M | 0.03M | -5.69M | 0.01M | |||||
| Profit After TaxPAT | -4.06M | -6.21M | -8.83M | -5.56M | -6.74M | -10.46M | -4.29M | -7.62M | -5.66M |
| Income from Continuing OperationsIncome (Continuing) | -4.06M | -6.21M | -4.43M | -5.56M | -6.72M | -10.43M | 1.37M | -7.62M | -5.66M |
| Consolidated Net IncomeConsol Net Inc. | -4.06M | -6.21M | -4.43M | -5.56M | -6.72M | -10.43M | 1.37M | -7.62M | -5.66M |
| Income towards Parent CompanyParent Net Inc | -4.06M | -6.21M | -4.43M | -5.56M | -6.72M | -10.43M | 1.37M | -7.62M | -5.66M |
| Preferred Dividend PaymentsPref Dividends | 0.68M | 0.67M | 0.78M | 0.80M | |||||
| Net Income towards Common StockholdersNet Income | -4.72M | -6.89M | -9.51M | -6.34M | -7.52M | -10.43M | -4.29M | -7.62M | -5.66M |
| Additional items | |||||||||
| EPS (Basic) | -29.72 | -43.36 | -59.85 | -39.81 | -42.62 | -9.57 | -5.92 | -5.12 | -3.05 |
| Shares Outstanding | 0.16M | 0.16M | 0.16M | 0.16M | 0.18M | 1.09M | 0.72M | 1.49M | 1.86M |
| EBITDA | -3.82M | -4.44M | -3.57M | -3.25M | -3.52M | -3.49M | -3.00M | -4.51M | -4.63M |
| Interest ExpensesInt Expense | 0.17M | 2.43M | |||||||
| Tax Rate | 49.94 | -0.56 | 131.74 | -0.12 |